NCT02132286View on ClinicalTrials.gov

Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Major Depressive Disorder
Interventions
DRUG

Quetiapine XR (extended release)

Treatment of quetiapine XR ( extended release)in MDD patients with S/Lg alleles

Trial Locations (1)

T2N4Z6

University of Calgary: Foothills medical centre, Calgary

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of Calgary

OTHER